Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Registry of Outcomes of Dezawa MuseCells®
Authors not listed
MuseCell Innovations Pte LTD · 2026
Abstract
The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases.
The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2026). Registry of Outcomes of Dezawa MuseCells®. <em>MuseCell Innovations Pte LTD</em>. https://clinicaltrials.gov/study/NCT07645989
Vancouver
Anonymous. Registry of Outcomes of Dezawa MuseCells®. MuseCell Innovations Pte LTD. 2026.
BibTeX
@misc{anon2026Regist,
title = {Registry of Outcomes of Dezawa MuseCells®},
author = {Anonymous},
journal = {MuseCell Innovations Pte LTD},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Second Affiliated Hospital of Nanchang University 2006
Open access · US-GOV
Phenotypic Age Acceleration (PhenoAgeAccel) for Joint Prediction of Disease Risk, Mortality Risk, Life Expectancy, and Disease-Free Healthspan in Major Chronic Diseases
Semmelweis University 2024
Open access · US-GOV
Noninvasive Testing Procedures, Role of Biomarkers and Anticancer Treatments in Esophageal and Esophagogastric Cancer Survival and Quality of Life of Patients With Cancer of the Esophageopharyngeal and Oesophageophageophageal Junction
Augusto Caraceni 2025
Open access · US-GOV
MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care
University of Calgary 2025
Open access · US-GOV
ADHD-Her: An Observational Research Protocol for Investigating Health, Equity, and Resilience (HER) in Girls and Women With ADHD Across the Lifespan
Trials 2023
Open access · CC-BY
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
BellAge Inc. 2026
Open access · US-GOV